Reporter

aspergillus culture
October 7, 2015

Rational design of novel antifungals

Structural and molecular details of an anti-fungal target’s interaction with inhibitors suggest ways to design better treatments for fungal infections.

By VUMC News and Communications
October 6, 2015

New VUMC messages hit airwaves this week

Television viewers in Middle Tennessee will begin to see new messages from Vanderbilt University Medical Center this week that build upon the “Promise of Discovery” theme to describe the Medical Center’s work and mission.

By VUMC News and Communications
flu shot
October 6, 2015

Flu vaccine helps reduce hospitalizations due to influenza pneumonia: study

More than half of hospitalizations due to influenza pneumonia could be prevented by influenza vaccination, according to a study led by investigators at Vanderbilt University Medical Center, published this week in the Journal of the American Medical Association.

By Paul Govern
October 5, 2015

Potential target for lung cancer therapy

The glutamine transporter protein appears to contribute to the survival of lung cancer cells, suggesting it may be a useful diagnostic biomarker and target for therapies.

By Leigh MacMillan
October 2, 2015

The yin and yang of COX-2

New findings add to the understanding of how the enzyme COX-2 works, which is critical to the development of COX-2-targeted anti-inflammatory drugs.

By Sanjay Mishra
arm with IV line
October 1, 2015

Major grant to transform region’s clinical practices

Vanderbilt University has received a contract from the Centers for Medicare and Medicaid Services (CMS) for up to $28 million over four years to help more than 4,000 clinicians in the Southeast transform their clinical practices in ways that improve quality of patient care and hold down costs.

By Bill Snyder
October 1, 2015

Collaboration seeks to develop new therapies for bone, other diseases

La Jolla Pharmaceutical Co. and Vanderbilt University have signed a research and license agreement covering Vanderbilt’s research program and intellectual property rights related to compounds that block bone morphogenetic protein (BMP) type-I receptors. The compounds have therapeutic potential in a broad range of diseases, including rare genetic disorders.
By Leigh MacMillan
October 1, 2015

Donation to bring computers to thousands of MNPS families

A few thousand families in the Metro Nashville Public Schools system will now have computers at home, thanks to Vanderbilt University Medical Center’s donation of 3,800 lightly used computers.
By Nancy Humphrey
October 1, 2015

Tolerating a transplant

A new genetic model has generated new strategies for promoting tolerance to transplants – and improving long-term transplant outcomes – in the background of autoimmune disease.
By Leigh MacMillan
October 1, 2015

New online system for animal research protocols set to launch

Animal Research Information Enterprise System (ARIES), a new online system for submitting animal research protocols, will be launched at Vanderbilt University on Oct. 12.
By Bill Snyder
October 1, 2015

Infants born with NAS more likely to be readmitted: Study

Infants diagnosed with drug withdrawal symptoms at birth, also known as neonatal abstinence syndrome (NAS), are nearly 2.5 times as likely to be readmitted to the hospital in the first month after being discharged compared with full-term infants born without complications, according to new Vanderbilt research released in the journal Hospital Pediatrics.
By Christina Echegaray
October 1, 2015

VUMC completes transition to new ICD-10 system

After months transitioning clinics across Vanderbilt University Medical Center and training clinicians and staff, the move to the new medical coding and reporting system is complete.
By VUMC News and Communications
October 1, 2015

VICC investigators land Komen breast cancer grants

Two Vanderbilt-Ingram Cancer Center (VICC) investigators — Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of VICC, and Valerie Jansen, M.D., Ph.D., medical oncology fellow — have received new cancer research grants awarded by Susan G. Komen, the world’s largest nonprofit funder of breast cancer research.
By VUMC News and Communications
1 … 455 456 457 458 459 … 717